Medicine and Dentistry
Hearing Impairment
100%
Cisplatin
75%
Ototoxicity
72%
Pediatrics
61%
Childhood Cancer
48%
Sodium Thiosulfate
43%
Cancer Therapy
37%
Oncology
35%
Brain Tumor
30%
Acetylcysteine
30%
Phase I Trials
30%
Hearing Assessment
30%
Germinoma
30%
DNA Template
30%
Quality of Life
16%
Arm
15%
Audiometry
15%
Malignant Neoplasm
14%
Survivorship in Cancer Care
13%
Cancer Treatment
13%
Late Effect
11%
Cohort Effect
10%
Neuro-Oncology
8%
Liver Tumor
7%
Adverse Event
6%
Genetic Susceptibility
6%
Translational Research
6%
Rank Sum Test
5%
Auditory Threshold
5%
Keyphrases
Hearing Loss in children
30%
Phase I Trial
30%
Brain Tumor Survivors
30%
Extended High-frequency Audiometry
30%
N-acetylcysteine
30%
Cisplatin-induced Hearing Loss
30%
Remote Fields
30%
Oncology Survivorship
20%
Extended High Frequency
10%
High-frequency Distortion
10%
Tablet Audiometry
10%
Childhood Liver Tumor
7%
International childhoods
7%
Control Arm
7%
Deep Integration
6%
Historical Paradigms
6%
Recommended Phase 2 Dose
5%
Cisplatin
5%
Confidence Interval
5%
Otoprotection
5%
Threshold Product
5%
Amplitude Range
5%
Frequency Distortion
5%
Pure Tone Audiometry
5%
Otoprotectant
5%
Assessment Characteristics
5%
Remote Application
5%
Nursing and Health Professions
Ototoxicity
60%
Cisplatin
39%
Cancer Therapy
38%
Hearing Impairment
31%
Audiometry
30%
Distortion Product Otoacoustic Emission
30%
Quality of Life
19%
Malignant Neoplasm
16%
Sodium Thiosulfate
15%
Childhood Cancer
15%
Carboplatin
8%
Sample Size
7%
Genetic Susceptibility
7%